Schizophrenia News: January 2013
The U.S. Food and Drug Administration (FDA) approved Adasuve (loxapine) for the acute treatment of agitation caused by schizophrenia or bipolar 1 disorder. Adasuve is the first non-injectable form of therapy for symptoms of agitation. Two phase 3 clinical trials involving 1,600 patients were carried out with either Adasuve or... Read more



10 Signs You May Be in an Emotionally Abusive Relationship
10 Warning Signs of Childhood Schizophrenia
7 Ways to Improve Your Mood
10 Schizophrenia Myths Busted